FOURNIER, C. Tebentafusp: A New Systemic Treatment for Unresectable or Metastatic Uveal Melanoma in HLA-A*02:01-positive patients. Canadian Dermatology Today, Toronto, Canada, v. 4, n. 3, p. 5–10, 2023. Disponível em: https://canadiandermatologytoday.com/article/view/4-3-fournier. Acesso em: 14 aug. 2024.